Neurocrine Biosciences CEO Kevin Gorman's 2020 pay jumps 47% to $14M

Neurocrine Biosciences reports 2020 executive compensation

By ExecPay News

Published: April 9, 2021

Neurocrine Biosciences reported fiscal year 2020 executive compensation information on April 9, 2021.
In 2020, five executives at Neurocrine Biosciences received on average a compensation package of $8M, a 35% increase compared to previous year.
Average pay of disclosed executives at Neurocrine Biosciences
Kevin C. Gorman, Chief Executive Officer, received $14M in total, which increased by 47% compared to 2019. 51% of Gorman's compensation, or $7.1M, was in option awards. Gorman also received $543K in bonus, $775K in salary, $5.4M in stock awards, as well as $63K in other compensation.
For fiscal year 2020, the median employee pay was $241,848 at Neurocrine Biosciences. Therefore, the ratio of Kevin C. Gorman's pay to the median employee pay was 57 to one.
Kyle W. Gano, Chief Development and Strategy Officer, received a compensation package of $7.2M, which increased by 53% compared to previous year. 52% of the compensation package, or $3.7M, was in option awards.
Eric Benevich, Chief Commercial Officer, earned $6.7M in 2020, a 16% increase compared to previous year.
Matthew C. Abernethy, Chief Financial Officer, received $6.3M in 2020, which increases by 8% compared to 2019.
Eiry W. Roberts, Chief Medical Officer, earned $5.8M in 2020, a 19% increase compared to previous year.

Related executives

Kevin Gorman

Neurocrine Biosciences

Chief Executive Officer

Matthew Abernethy

Neurocrine Biosciences

Chief Financial Officer

Eric Benevich

Neurocrine Biosciences

Chief Commercial Officer

Kyle Gano

Neurocrine Biosciences

Chief Development and Strategy Officer

Eiry Roberts

Neurocrine Biosciences

Chief Medical Officer

You may also like

Source: SEC filing on April 9, 2021.